𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes

✍ Scribed by F. Labrousse-Lhermine; L. Cazals; J.-B. Ruidavets; H. Hanaire

Book ID
116404668
Publisher
Masson Editeur
Year
2007
Tongue
French
Weight
288 KB
Volume
33
Category
Article
ISSN
1262-3636

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Improvement of cardiovascular risk facto
Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion
✍ Yun-Hee Noh; Se-Myung Lee; Eun-Ju Kim; Do-Young Kim; Hyunil Lee; Jun-Ho Lee; Ju- πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 152 KB πŸ‘ 1 views

## Abstract ## Background The effects of long‐term continuous subcutaneous insulin infusion (CSII) on cardiovascular risk factors such as hyperglycaemia, dyslipidaemia, and proinflammatory cytokine levels have not been assessed so far in type 2 diabetes. ## Methods We analysed the levels of HbA~

Induction of long-term normoglycemia wit
Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy
✍ Sunmin Park; Soo Bong Choi πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

## Abstract ## Background Our previous studies showed that some Korean type 2 diabetic patients could maintain long‐term normal blood glucose control without any medication, referred to as remission after a certain period of normalization of blood glucose level by continuous subcutaneous insulin i

Effects of the combination of insulin an
Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents
✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. TΓΆtterman; F. Fyhrqvist; L. Groop πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa